Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 85
Filter
2.
Blood Cancer J ; 7(1): e516, 2017 01 06.
Article in English | MEDLINE | ID: mdl-28157189

ABSTRACT

Recent genetic analysis has identified frequent mutations in ten-eleven translocation 2 (TET2), DNA methyltransferase 3A (DNMT3A), isocitrate dehydrogenase 2 (IDH2) and ras homolog family member A (RHOA) in nodal T-cell lymphomas, including angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, not otherwise specified. We examined the distribution of mutations in these subtypes of mature T-/natural killer cell neoplasms to determine their clonal architecture. Targeted sequencing was performed for 71 genes in tumor-derived DNA of 87 cases. The mutations were then analyzed in a programmed death-1 (PD1)-positive population enriched with tumor cells and CD20-positive B cells purified by laser microdissection from 19 cases. TET2 and DNMT3A mutations were identified in both the PD1+ cells and the CD20+ cells in 15/16 and 4/7 cases, respectively. All the RHOA and IDH2 mutations were confined to the PD1+ cells, indicating that some, including RHOA and IDH2 mutations, being specific events in tumor cells. Notably, we found that all NOTCH1 mutations were detected only in the CD20+ cells. In conclusion, we identified both B- as well as T-cell-specific mutations, and mutations common to both T and B cells. These findings indicate the expansion of a clone after multistep and multilineal acquisition of gene mutations.


Subject(s)
Biomarkers, Tumor , Lymphoma, Extranodal NK-T-Cell/genetics , Mutation , Alleles , Amino Acid Substitution , B-Lymphocytes/metabolism , B-Lymphocytes/pathology , DNA Methyltransferase 3A , Gene Rearrangement, T-Lymphocyte , Genetic Predisposition to Disease , Humans , Immunoglobulin Heavy Chains/genetics , Immunohistochemistry , Immunophenotyping , Lymphoma, Extranodal NK-T-Cell/metabolism , Lymphoma, Extranodal NK-T-Cell/pathology , Organ Specificity/genetics , Phenotype , Sequence Analysis, DNA , V(D)J Recombination , rhoA GTP-Binding Protein/genetics , rhoA GTP-Binding Protein/metabolism
3.
Osteoarthritis Cartilage ; 20(3): 241-9, 2012 Mar.
Article in English | MEDLINE | ID: mdl-22233812

ABSTRACT

OBJECTIVE: To analyze changes in the capsule from idiopathic frozen shoulders and clarify their etiology. MATERIALS AND METHODS: Samples (the rotator interval capsule, middle glenohumeral ligament (MGHL), and inferior glenohumeral ligament (IGHL)) were collected from 12 idiopathic frozen shoulders with severe stiffness and 18 shoulders with rotator cuff tears as a control. The number of cells was counted and the tissue elasticity of the samples was calculated by scanning acoustic microscopy (SAM). The amount of glycosaminoglycan content was assessed by alcian blue staining. Gene and protein expressions related to fibrosis, inflammation, and chondrogenesis were analyzed by quantitative polymerase chain reaction (qPCR) and immunohistochemistry (IHC). Furthermore, the total genes of the two groups were compared by DNA microarray analysis. RESULTS: The number of cells was significantly higher and the capsular tissue was significantly stiffer in idiopathic frozen shoulders compared with shoulders with rotator cuff tears. Staining intensity of alcian blue was significantly stronger in idiopathic frozen shoulders. Gene expressions related to fibrosis, inflammation, and chondrogenesis were significantly higher in idiopathic frozen shoulders compared with shoulders with rotator cuff tears assessed by both qPCR and DNA microarray analysis. CONCLUSION: In addition to fibrosis and inflammation, which used to be considered the main pathology of frozen shoulders, chondrogenesis is likely to have a critical role in pathogenesis of idiopathic frozen shoulders.


Subject(s)
Bursitis/pathology , Chondrogenesis/physiology , Joint Capsule/pathology , Shoulder Joint/pathology , Adult , Bursitis/metabolism , Bursitis/physiopathology , Elasticity , Female , Fibrosis , Gene Expression Profiling/methods , Humans , Inflammation/metabolism , Inflammation/pathology , Inflammation/physiopathology , Joint Capsule/metabolism , Joint Capsule/physiopathology , Male , Microscopy, Acoustic , Middle Aged , Oligonucleotide Array Sequence Analysis/methods , Real-Time Polymerase Chain Reaction/methods , Rotator Cuff/pathology , Rotator Cuff Injuries , Shoulder Joint/metabolism , Shoulder Joint/physiopathology
4.
Br J Cancer ; 101(11): 1884-90, 2009 Dec 01.
Article in English | MEDLINE | ID: mdl-19888220

ABSTRACT

BACKGROUND: To enhance the success rate of nanocarrier-mediated chemotherapy combined with an anti-angiogenic agent, it is crucial to identify parameters for tumour vasculature that can predict a response to the treatment of the anti-angiogenic agent. METHODS: To apply transforming growth factor (TGF)-beta type I receptor (TbetaR-I) inhibitor, A-83-01, to combined therapy, dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) was carried out in mice bearing colon 26 cells using gadolinium (Gd)-DTPA and for its liposomal formulation to evaluate changes in tumour microvasculature following A-83-01. Tumour vascular parameters from DCE-MRI were compared with histological assessment and apparent diffusion coefficient of water in tumour generated by diffusion-weighted MRI. RESULTS: Contrary to evaluations reported for anti-angiogenic agents, A-83-01 treatment increased the initial area under the Gd concentration-time curve (IAUGC60), volume transfer constant (K(trans)) and fractional plasma volume (v(p)) significantly within 24 h, that was positively related to alpha-smooth muscle actin-positive pericyte coverage and tumour cell proliferation, and was correlated inversely with the apparent diffusion coefficient. The vascular function of the tumour improved by A-83-01 treatment was well assessed on post-liposomal Gd-DTPA-enhanced MR images, which predicted delivery of a liposomal drug to the tumour. CONCLUSION: These findings suggest that DCE-MRI and, in particular, K(trans) and v(p) quantitation, provide important additional information about tumour vasculature by A-83-01 treatment.


Subject(s)
Diffusion Magnetic Resonance Imaging/methods , Gadolinium DTPA/pharmacokinetics , Neoplasms, Experimental/blood supply , Protein Serine-Threonine Kinases/antagonists & inhibitors , Pyrazoles/pharmacology , Receptors, Transforming Growth Factor beta/antagonists & inhibitors , Thiocarbamates/pharmacology , Animals , Capillary Permeability/drug effects , Cell Growth Processes/drug effects , Cell Line, Tumor , Contrast Media , Endothelial Cells/drug effects , Endothelial Cells/metabolism , Female , Humans , Mice , Neoplasms, Experimental/drug therapy , Neoplasms, Experimental/metabolism , Neoplasms, Experimental/pathology , Neovascularization, Pathologic/drug therapy , Neovascularization, Pathologic/metabolism , Neovascularization, Pathologic/pathology , Receptor, Transforming Growth Factor-beta Type I , Thiosemicarbazones
5.
Kyobu Geka ; 56(11): 973-6, 2003 Oct.
Article in Japanese | MEDLINE | ID: mdl-14579703

ABSTRACT

We reported a successful case of emergent total arch replacement for a nonagenarian with acute Stanford A aortic dissection. A 92-year-old woman complained of general fatigue, with hypotension. Echocardiography showed moderate pericardial effusion and aortic regurgitation. Computed tomography (CT) scan showed widely extended aortic dissection from the ascending aorta to descending thoracic aorta, and cardiac tamponade. An emergent total arch replacement was performed under hypothermic selective cerebral perfusion with bladder temperature of 22.5 degrees C. Although she suffered from pneumothorax, renal insufficiency and gastrointestinal (GI) bleeding postoperatively, she tolerated the operation and complications, well. She is now leading a good life with the same level of activities of daily living (ADL) as preoperative one.


Subject(s)
Aortic Aneurysm, Thoracic/surgery , Aortic Dissection/surgery , Blood Vessel Prosthesis Implantation , Activities of Daily Living , Aged , Aged, 80 and over , Aorta/surgery , Aorta, Thoracic/surgery , Female , Humans
6.
Jpn J Thorac Cardiovasc Surg ; 49(6): 365-7, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11481839

ABSTRACT

A 78-year-old woman with an aortic root aneurysm and aortic regurgitation developing acute type A dissection successfully underwent aortic root replacement using a stentless xenograft during core cooling, followed by total aortic arch replacement under selective cerebral perfusion with deep hypothermia. This bioprosthesis can be used in the same way as a free-hand homograft and potentially provides an aggressive, safe option for acute aortic dissection requiring aortic root reconstruction in elderly patients.


Subject(s)
Aorta, Thoracic/surgery , Aorta/surgery , Aortic Aneurysm/surgery , Aortic Dissection/surgery , Bioprosthesis , Blood Vessel Prosthesis Implantation , Acute Disease , Aged , Female , Humans
8.
J Biosci Bioeng ; 91(3): 311-3, 2001.
Article in English | MEDLINE | ID: mdl-16232995

ABSTRACT

Microalgal cultivation in a solution recovered from the low-temperature catalytic gasification of the microalga itself was studied. The growth of Chlorella vulgaris in 75-300-fold diluted recovered solution containing phosphate, magnesium ions and micro-elements was comparable to that in the standard culture medium. It was suggested that C. vulgaris could use ammonium in the recovered solution as its nitrogen source and at the same time could provide a source of biomass which was recycled via gasification.

9.
J Gastroenterol ; 35(7): 536-9, 2000.
Article in English | MEDLINE | ID: mdl-10905362

ABSTRACT

We conducted a randomized prospective comparative study to determine whether a 1-week lansoprazole-amoxicillin-clarithromycin (LAC) regimen with 800 mg of clarithromycin a day was more effective such a regimen with 400 mg daily in the Japanese population. One hundred and seventy-five Helicobacter pylori-positive patients were randomly assigned to receive one of two different 7-day regimens, one with clarithromycin 400 mg (LAC 400 regimen) and the other with clarithromycin 800 mg (LAC 800 regimen). The cure rates for both regimens were similar, although adverse effects were significantly more frequent in the LAC 800 regimen, suggesting that 400 mg of clarithromycin may be sufficient in our patient population.


Subject(s)
Amoxicillin/therapeutic use , Anti-Bacterial Agents/therapeutic use , Clarithromycin/administration & dosage , Helicobacter Infections/drug therapy , Helicobacter pylori , Omeprazole/analogs & derivatives , Penicillins/therapeutic use , 2-Pyridinylmethylsulfinylbenzimidazoles , Drug Therapy, Combination , Humans , Japan , Lansoprazole , Omeprazole/therapeutic use , Prospective Studies , Sensitivity and Specificity
10.
Nature ; 406(6792): 203-7, 2000 Jul 13.
Article in English | MEDLINE | ID: mdl-10910363

ABSTRACT

Cholesteryl ester transfer protein (CETP) is a plasma protein that mediates the exchange of cholesteryl ester in high-density lipoprotein (HDL) for triglyceride in very low density lipoprotein (VLDL). This process decreases the level of anti-atherogenic HDL cholesterol and increases pro-atherogenic VLDL and low density lipoprotein (LDL) cholesterol, so CETP is potentially atherogenic. On the other hand, CETP could also be anti-atherogenic, because it participates in reverse cholesterol transport (transfer of cholesterol from peripheral cells through the plasma to the liver). Because the role of CETP in atherosclerosis remains unclear, we have attempted to develop a potent and specific CETP inhibitor. Here we describe CETP inhibitors that form a disulphide bond with CETP, and present one such inhibitor (JTT-705) that increases HDL cholesterol, decreases non-HDL cholesterol and inhibits the progression of atherosclerosis in rabbits. Our findings indicate that CETP may be atherogenic in vivo and that JTT-705 may be a potential anti-atherogenic drug.


Subject(s)
Arteriosclerosis/prevention & control , Carrier Proteins/antagonists & inhibitors , Cholesterol Esters , Glycoproteins , Sulfhydryl Compounds/pharmacology , Amides , Animals , Carrier Proteins/blood , Carrier Proteins/physiology , Cell Line , Cholesterol Ester Transfer Proteins , Cholesterol, HDL/blood , Disulfides/chemistry , Disulfides/pharmacology , Esters , Humans , Male , Rabbits , Structure-Activity Relationship , Sulfhydryl Compounds/chemistry
11.
Electrophoresis ; 21(9): 1782-6, 2000 May.
Article in English | MEDLINE | ID: mdl-10870965

ABSTRACT

Mutations of the adenomatous polyposis coli gene (APC) have been implicated in the occurrence of sporadic colon cancer. Various APC mutant strains of mice have been created to better understand the function of this gene. Previously, we had mice express a mutant form of mRNA of the APC protein that encoded 474 amino acids instead of the 2845 amino acids due to exon duplication. These APC mutant mice (APC delta 474) developed intestinal and mammary tumors, as have other APC mutant mice previously reported (Sasai, H., et al. Carcinogenesis, in press). To elucidate the mechanism of the tumor development, we prepared protein samples from both normal and tumor tissues from APC delta 474 mutant mice, as well as tissues from normal mice, and used them for proteomic analysis. After two-dimensional electrophoresis, the gels were silver stained and the protein spots were analyzed. We analyzed about 1000 protein spots per sample and found several protein spots that are specific for normal or tumor samples from APC delta 474 mutant mice, as well as proteins with altered expression levels. Among the identified protein spots, truncated beta-tubulins were specific to APC delta 474 mutant mice polyp samples. The apparent molecular mass of these proteins suggested that these beta-tubulins may be truncated very close to the binding site of the anti-tumor drug taxol.


Subject(s)
Colon/chemistry , Intestinal Mucosa/chemistry , Intestine, Small/chemistry , Neoplasm Proteins/analysis , Proteome/analysis , Adenomatous Polyposis Coli/pathology , Amino Acid Sequence , Animals , Colon/pathology , Electrophoresis, Gel, Two-Dimensional/methods , Genes, APC , Intestinal Mucosa/pathology , Intestine, Small/pathology , Mice , Mice, Mutant Strains , Molecular Sequence Data
12.
Aliment Pharmacol Ther ; 14 Suppl 1: 161-5, 2000 Apr.
Article in English | MEDLINE | ID: mdl-10807418

ABSTRACT

AIM: To investigate the incidence of reflux oesophagitis after antibacterial therapy for Helicobacter pylori infection in our patient population. METHODS: Subjects were 451 H. pylori-infected patients (primary symptom: peptic ulcer disease in 347, nonulcer dyspepsia in 100, and reflux oesophagitis in four): 11 of these patients had reflux oesophagitis on study entry. H. pylori infection was treated by a proton pump inhibitor/amoxycillin-clarithromycin regimen for either 7 or 14 days. Each patient was examined by endoscopy before treatment and more than 6 months after treatment to compare oesophageal findings. In addition, 227 patients were interviewed regarding reflux symptoms, using symptom questionnaires, before and more than 6 months after treatment. RESULTS: Among 440 patients who did not have reflux oesophagitis prior to antibacterial treatment (340 peptic ulcer patients and 100 nonulcer dyspepsia patients), 23 patients whose infection was eradicated developed reflux oesophagitis (5.4%). The 11 patients who had reflux oesophagitis prior to treatment were all successfully cured of infection. Six of these patients showed no change in their oesophagitis, while the condition improved in three and worsened in two. Symptom scores improved in 34 of the 36 patients who reported reflux symptoms. Among 19 patients who showed persistent infection, only one developed reflux oesophagitis (5.2%), while none complained of newly developed symptoms following treatment. CONCLUSIONS: Development of reflux oesophagitis after treatment of H. pylori infection was observed in a Japanese population. However, the incidence of this condition was comparable between those with persistent H. pylori infection and those in whom the infection was eradicated.


Subject(s)
Esophagitis, Peptic/epidemiology , Helicobacter Infections/complications , Adult , Anti-Bacterial Agents/therapeutic use , Esophagitis, Peptic/microbiology , Female , Helicobacter Infections/drug therapy , Humans , Incidence , Japan/epidemiology , Male , Middle Aged , Peptic Ulcer/complications , Retrospective Studies
13.
Ann Thorac Surg ; 68(3): 864-9, 1999 Sep.
Article in English | MEDLINE | ID: mdl-10509975

ABSTRACT

BACKGROUND: Optimal conditions for deep hypothermic perfusion and protective brain blood flow remain unclear. METHODS: Dogs (n = 52) underwent 120 minutes of cardiopulmonary bypass at 20 degrees C with perfusion flow rates of 2.5, 5, 10, 20, 40, and 100 mL x kg(-1) x min(-1). We examined the effect of the various flow rates and different perfusion pressures on brain blood flow, metabolism, and intracellular pH. RESULTS: The brain was ischemic and acidotic when the perfusion flow rate was less than 5 mL kg(-1) x min(-1) and pressure was less than 10 mm Hg. When perfusion pressure was higher than 10 mm Hg, cerebral cortex blood flow was more than 9 mL x 100 g(-1) x min(-1) and intracellular pH, higher than 6.95. The cerebral metabolic rate for oxygen decreased at a flow rate of 2.5 mL x kg(-1) min(-1). The cerebral metabolic ratio of glucose to oxygen and the cerebral vascular resistance were lowest when perfusion pressure was 10 to 30 mm Hg. Full-flow (100 mL x kg(-1) x min(-1)) perfusion caused paradoxical brain acidosis; a flow of 40 mL x kg(-1) x min(-1) provided the best results. CONCLUSIONS: Both extremely low-flow perfusion and excessive perfusion cause brain acidosis. Low-flow perfusion at a pressure of 20 mm Hg provides cerebral vasorelaxation and aerobic metabolism during operations at 20 degrees C.


Subject(s)
Cardiopulmonary Bypass , Cerebrovascular Circulation , Hypothermia, Induced , Animals , Blood Flow Velocity , Brain/metabolism , Cerebral Cortex/blood supply , Dogs , Glucose/metabolism , Hydrogen-Ion Concentration , Oxygen Consumption , Vascular Resistance
15.
Br J Pharmacol ; 127(6): 1388-98, 1999 Jul.
Article in English | MEDLINE | ID: mdl-10455288

ABSTRACT

We have recently shown that endothelin-1 (ET-1) activates two types of Ca2+-permeable nonselective cation channels (designated NSCC-1 and NSCC-2) and store-operated Ca2+ channel (SOCC). These channels can be pharmacologically discriminated using Ca2+ channel blockers such as SK&F 96365 and LOE 908. Here we characterized Ca2+ entry channels involved in ET-1-induced contractions of rat thoracic aortic rings and increases in the intracellular free Ca2+ concentration ([Ca2+]i) of single smooth muscle cells using these blockers. LOE 908 or a blocker of voltage-operated Ca2+ channel nifedipine had no effect on the contractions and increases in [Ca2+]i induced by thapsigargin or ionomycin, whereas SK&F 96365 abolished them. The contractions and increases in [Ca2+]i induced by ET-1 depended on extracellular Ca2+ but were resistant to nifedipine. The responses to lower concentrations (< or =0.1 nM) of ET-1 were abolished by either SK&F 96365 or LOE 908. The responses to higher concentrations (> or = 1 nM) were abolished by SK&F 96365, but were partially resistant to LOE 908. SK&F 96365 inhibited the LOE 908-resistant contractions induced by higher concentrations of ET-1 with IC50 values similar to those for contractions induced by thapsigargin or ionomycin. These results show that the contractions and increases in [Ca2+]i of rat aortic smooth muscles at lower concentrations of ET-1 involve only one Ca2+ entry channel which is sensitive to SK&F 96365 and LOE 908 (NSCC-2), whereas those at higher concentrations of ET-1 involve another Ca2+ entry channel which is sensitive to SK&F 96365 but resistant to LOE 908 (SOCC) in addition to the former channel.


Subject(s)
Acetamides/pharmacology , Aorta, Thoracic/drug effects , Calcium Channels/drug effects , Endothelin-1/pharmacology , Imidazoles/pharmacology , Isoquinolines/pharmacology , Muscle Contraction/drug effects , Animals , Aorta, Thoracic/physiology , Calcium/metabolism , Calcium/pharmacology , Calcium Channel Blockers/pharmacology , Calcium Channels/metabolism , Cells, Cultured , Dose-Response Relationship, Drug , Male , Muscle, Smooth, Vascular/cytology , Muscle, Smooth, Vascular/drug effects , Muscle, Smooth, Vascular/metabolism , Nifedipine/pharmacology , Rats , Rats, Wistar
16.
Br J Pharmacol ; 126(5): 1107-14, 1999 Mar.
Article in English | MEDLINE | ID: mdl-10204997

ABSTRACT

1. We have shown that in addition to voltage-operated Ca2+ channel (VOC), endothelin-1 (ET-1) activates two types of Ca2+-permeable nonselective cation channel (NSCC) in A7r5 cells: its lower concentrations (< or = 1 nM; lower [ET-1]) activate only an SK&F 96365-resistant channel (NSCC-1), whereas its higher concentrations (> or = 10 nM; higher [ET-1]) activate an SK&F 96365-sensitive channel (NSCC-2) as well. 2. We now characterized the effects of a blocker of Ca2+ entry channel LOE 908 on NSCCs and store-operated Ca2+ channel (SOCC) in A7r5 cells, and using two drugs, clarified the involvement of these channels in the ET-1-induced increase in the intracellular free Ca2+ concentrations ([Ca2+]i). Whole-cell recordings and [Ca2+]i monitoring with fluo-3 were used. 3. LOE 908 up to 10 microM had no effect on increases in [Ca2+]i induced by thapsigargin or ionomycin, but SK&F 96365 abolished them. 4. In the cells clamped at -60 mV, both lower and higher [ET-1] induced inward currents with linear iv relationships and the reversal potentials of -15.0 mV. Thapsigargin induced no currents. 5. In the presence of nifedipine, lower [ET-1] induced a sustained increase in [Ca2+]i, whereas higher [ET-1] induced a transient peak and a sustained increase. The sustained increases by lower and higher [ET-1] were abolished by removal of extracellular Ca2+, and they were suppressed by LOE 908 to 0 and 35%, respectively, with the LOE 908-resistant part being abolished by SK&F 96365. 6. These results show that LOE 908 is a blocker of NSCCs without effect on SOCC, and that the increase in [Ca2+]i at lower [ET-1] results from Ca2+ entry through NSCC-1 in addition to VOC, whereas the increase at higher [ET-1] involves NSCC-1, NSCC-2 and SOCC in addition to VOC.


Subject(s)
Acetamides/pharmacology , Calcium Channel Blockers/pharmacology , Calcium Channels/metabolism , Endothelin-1/metabolism , Isoquinolines/pharmacology , Animals , Calcium/physiology , Cations/metabolism , Cells, Cultured , Drug Interactions , Imidazoles/pharmacology , Ionomycin/pharmacology , Patch-Clamp Techniques , Rats , Thapsigargin/pharmacology
17.
Kyobu Geka ; 52(3): 192-6, 1999 Mar.
Article in Japanese | MEDLINE | ID: mdl-10097544

ABSTRACT

Delayed cardiac tamponade is an unusual but serious complication of cardiac surgery. Echocardiography and computed tomography (CT) are well established methods for the detection of pericardial effusions. Catheter insertion guided by CT has been used to accomplish non operative drainage of symptomatic postoperative pericardial effusion in seven cases. These patients were grouped into four types according to distribution of the fluid. General pericardial effusion around the heart is classified as type 1, effusion adjacent to the right side of the heart as type 2 and left side as type 3, effusion localized only at the apex as type 4. CT imaging is useful not only to localize and assess the size of the effusions, but also to select the way of catheter insertion. As the fluid might be trapped in compartments, for instance right-sided or left sided type, investigation of the pericardial spaces is important in planning a catheter pericardiocentesis.


Subject(s)
Cardiac Tamponade/therapy , Drainage/methods , Pericardial Effusion/therapy , Postoperative Complications/therapy , Tomography, X-Ray Computed , Aged , Cardiac Tamponade/etiology , Coronary Artery Bypass , Female , Heart Valve Prosthesis Implantation , Humans , Male , Middle Aged , Pericardial Effusion/etiology
18.
Kyobu Geka ; 52(3): 218-23, 1999 Mar.
Article in Japanese | MEDLINE | ID: mdl-10097549

ABSTRACT

Between 1978 and 1997, 9 patients developed poststernotomy mediastinitis after coronary artery bypass grafting. Four of these patients (group A) were treated with open drainage and mediastinal irrigation or omental transfer. The other 5 patients (group B) were treated with primary wound closure by the technique of muscle flap mobilization. The purpose of this study was to compare the surgical results and graft patency of both groups. The hospital mortality of group A was 100 per cent. All patients in group B survived for 35 months of the mean postoperative periods without complaints. Postoperative coronary angiography revealed the complete graft patency in group B. We conclude that muscle flap mobilization may be a superior measure for the patient survival and graft patency as the treatment of mediastinitis after coronary artery bypass grafting.


Subject(s)
Coronary Artery Bypass , Mediastinitis/surgery , Omentum/transplantation , Postoperative Complications/surgery , Surgical Flaps , Vascular Patency , Aged , Drainage , Female , Humans , Male , Middle Aged , Treatment Outcome
19.
Artif Organs ; 23(12): 1107-12, 1999 Dec.
Article in English | MEDLINE | ID: mdl-10619929

ABSTRACT

The effects of Duraflo II heparin coated cardiopulmonary bypass circuits, low-dose aprotinin, and steroids on the coagulation system, endothelial damage, and cytokine release were evaluated by comparing those treated with low-dose aprotinin and steroids. Twenty-four adult patients undergoing coronary artery bypass grafting, aortic valve replacement, or valve repair surgery were randomly assigned to 2 groups: either heparin-coated (Duraflo group, n = 12) or noncoated equipment (noncoated group, n = 12) groups. In the Duraflo group, the cardiopulmonary reservoir was also coated with heparin. There were no significant differences in age at the time of operation, aortic cross-clamp time, cardiopulmonary bypass time, and rectal temperature during cardiopulmonary bypass. Standard systemic heparinization was performed. Methylpredonisolone and low-dose aprotinin were given in both groups of patients. Serum XIIa factor, TAT, and IL-6 were significantly higher in the control group than in the Duraflo group during cardiopulmonary bypass (p < 0.01). Serum IL-8 was significantly higher in the control group than in the Duraflo group at 24 h after cardiopulmonary bypass (p < 0.05). No significant difference was found in serum thrombomodulin and TNF-alpha; both were within normal during the study period. These results indicate that the use of Duraflo II heparin coated equipment and a heparin-coated cardiopulmonary reservoir suppressed excess coagulation and inflammatory reaction induced by cardiopulmonary bypass.


Subject(s)
Blood Coagulation/drug effects , Cardiopulmonary Bypass/instrumentation , Coated Materials, Biocompatible/pharmacology , Cytokines/metabolism , Endothelium, Vascular/drug effects , Heparin/pharmacology , Inflammation/prevention & control , Aged , Analysis of Variance , Anti-Inflammatory Agents/pharmacology , Aprotinin/pharmacology , Enzyme-Linked Immunosorbent Assay , Female , Hemostatics/pharmacology , Humans , Male , Methylprednisolone/pharmacology , Middle Aged
20.
Kyobu Geka ; 51(13): 1120-2, 1998 Dec.
Article in Japanese | MEDLINE | ID: mdl-9866347

ABSTRACT

We reported a case with severe mitral regurgitation caused by total rupture of the posterior papillary muscle two days after aortic valve replacement. A 62-year-old man was transferred to our hospital with high fever and dyspnea with severe aortic regurgitation caused by infective endocarditis. The left heart failure occurred suddenly two days after the initial operation. Echocardiogram revealed massive mitral regurgitation and rupture of the posterior papillary muscle. He underwent emergent mitral valve replacement. Histological examination of the papillary muscle showed typical ischemic necrosis without inflammation. The postoperative course was uneventful. We suggested the papillary muscle rupture in this case may be due to coronary artery emboli occurred in association with infective endocarditis.


Subject(s)
Aortic Valve/surgery , Endocarditis, Bacterial/surgery , Heart Rupture/surgery , Heart Valve Prosthesis Implantation , Papillary Muscles , Postoperative Complications/surgery , Bioprosthesis , Heart Rupture/etiology , Humans , Male , Middle Aged , Mitral Valve/surgery , Mitral Valve Insufficiency/etiology , Mitral Valve Insufficiency/surgery
SELECTION OF CITATIONS
SEARCH DETAIL
...